| Literature DB >> 32357275 |
Yurong Li1, Ning Yang1, Xiaoxiao Li1, Junpeng Wang1, Tianzhong Yan1.
Abstract
To summarize measures for the prevention and control of the 2019 novel coronavirus disease (COVID-19) in the department of kidney transplantation. We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, and follow-up management of discharged patients after kidney transplantation. During the epidemic period, there were no COVID-19 cases among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital, and 30 medical staff. There were no COVID-19 cases among 160 follow-up recipients after kidney transplantation and 60 patients waiting for kidney transplantation. During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure safe and orderly work of the department.Entities:
Keywords: 2019 novel coronavirus disease; kidney transplant; pneumonia; prevention and control
Mesh:
Year: 2020 PMID: 32357275 PMCID: PMC7267566 DOI: 10.1111/tri.13634
Source DB: PubMed Journal: Transpl Int ISSN: 0934-0874 Impact factor: 3.842
Workflow adjustment program for kidney transplantation under the COVID‐19 epidemic.
| Transplant processes | Adjustment methods |
|---|---|
| Donor and recipient screening |
Within 14 days, the donor or the recipient had no history of staying in the epidemic area and no history of contact with COVID‐19 patients. None of the people in close contact with them had a history of sojourn in the epidemic area There are no fever, progressive dyspnea, dry cough, diarrhea, and other related symptoms within 14 days before the onset of the primary disease Chest CT and laboratory examination showed no pneumonia Nasopharyngeal swabs, sputum, lower respiratory tract secretions, blood, feces, and other specimens tested negative for new coronavirus nucleic acid All were limited to one escort, who had no epidemiological history and normal body temperature The hospital ethics committee examines the authenticity of the worker's willingness to donate and the legality of the source of the donor |
| Donor maintenance |
Single‐room medical unit, fixed personnel to participate in the maintenance Screening the coordinator and donor and transplant staff The apparatus and equipment needed for organ acquisition shall be packed with protection; after the operation is completed, store the protective layer of the outer packaging of the instruments should in a centralized manner and dispose of it medical waste as medical waste contaminated by viruses; after the acquisition personnel return, sterilize the exterior of the organ preservation device, refrigerator, and other instruments |
| Operation and postoperative management |
Strengthen the health investigation and management of medical staff Independent operating room and postoperative laminar flow ward In case of suspected infection of COVID‐19 during the perioperative period, the transplant recipient shall be isolated in a single room immediately and report to the relevant department of the hospital for consultation. When the patient is confirmed to be infected with COVID‐19, the patient is transferred to the special ward of the hospital immediately and the medical staff who contacted the patient are isolated for 14 days Strict implementation of disinfection and isolation system Implement the system of professional responsible persons to improve the quality of care |